Related references
Note: Only part of the references are listed.Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Risk of COVID-19 for patients with cancer
Hanping Wang et al.
LANCET ONCOLOGY (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A War on Two Fronts: Cancer Care in the Time of COVID-19
Alexander Kutikov et al.
ANNALS OF INTERNAL MEDICINE (2020)
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
L. Zhang et al.
ANNALS OF ONCOLOGY (2020)
Estimating case fatality rates of COVID-19
Piotr Spychalski et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19: global consequences for oncology
The Lancet Oncology
LANCET ONCOLOGY (2020)
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
Marie Von Lilienfeld-Toal et al.
LEUKEMIA (2020)
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Jing Yu et al.
JAMA ONCOLOGY (2020)
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells
Daniela Doerfel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much
Robert Peter Gale et al.
LEUKEMIA RESEARCH (2017)
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
S. Thiant et al.
BLOOD CANCER JOURNAL (2017)
Profound inhibition of antigen-specific T-cell effector functions by dasatinib
Ralf Weichsel et al.
CLINICAL CANCER RESEARCH (2008)
Share Paper
